Joseph A Kovacs MD

Infectious Disease•Bethesda, MD

Physician

Join to View Full Profile

Msc 1662 Institutes Of HealtBldg 10Bethesda, MD 20892
Phone+1 301-496-9320
Fax+1 301-402-1213

Education & Training

National Institutes of Health Clinical CenterFellowship, Critical Care Medicine (Internal Medicine), 1982 - 1987
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1979 - 1982
Weill Cornell MedicineClass of 1979

Certifications & Licensure

NY State Medical License 1980 - Present
MD State Medical License 1983 - 2026
DC State Medical License 2008 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1994

Clinical Trials

Tissue Biopsy and Imaging Studies in HIV-Infected Patients Start of enrollment: 1994 Nov 30
RECRUITING
Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients Start of enrollment: 1998 Feb 25
Terminated
Not Applicable
Magnetic Resonance Imaging of the Face and Bones Start of enrollment: 1998 Feb 23
Completed
Development of Serologic Assays for Human Herpes Virus-8 Start of enrollment: 2006 Oct 30
Completed
Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy Start of enrollment: 2007 Nov 08
Terminated
Phase 1
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections Start of enrollment: 2010 Sep 01
Terminated
Antiretroviral Drug Interaction Study in Volunteers With HIV Start of enrollment: 2011 Oct 31
Completed
Phase 1
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia Start of enrollment: 1999 Sep 28
RECRUITING
Roles: Contact, Principal Investigator
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA) Start of enrollment: 2018 Jun 12
COMPLETED
PHASE1
Roles: Contact, Principal Investigator
A Single Dose of Pembrolizumab in HIV-Infected People Start of enrollment: 2018 Aug 06
TERMINATED
PHASE1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

CD4, but not Cxcr6, is necessary for control of Pneumocystis murina infection.
Lisa R Bishop, Matthew F Starost, Joseph A Kovacs
Microbes and Infection. 2025-02-01
Evolving spectrum of Pneumocystis host specificity, genetic diversity, and evolution.
Liang Ma, Christiane Weissenbacher-Lang, Alice Latinne, Spenser Babb-Biernacki, Barbara Blasi
FEMS Microbiology Reviews. 2025-01-14
2 citations
CD40 Expression by B Cells Is Required for Optimal Immunity to Murine Pneumocystis Infection.
Monica Sassi, Shelly J Curran, Lisa R Bishop, Yueqin Liu, Joseph A Kovacs
The Journal of Infectious Diseases. 2024-10-16

Grant Support

Characterization Of Immune Responses During Pneumocystis PneumoniaClinical Center2007–2008
The Characterization Of Pneumocystis Surface AntigensClinical Center2005–2008
Evaluation Of Hiv-Related ComplicationsClinical Center2005–2008
Studies On The Role Of Interleukin-2 In The Management Of HIV InfectionClinical Center1998–2008
Studies Of Lymphocyte Kinetics In Healthy And Hiv-Infected PatientsClinical Center1998–2008
Molecular Studies Of Human Pneumocystis CariniiClinical Center1998–2008
Studies On The Role Of Interleukin-2 In The Management OClinical Center2002–2006
Studies Of Lymphocyte Kinetics In Healthy And Hiv-InfectClinical Center2001–2006
Characterization Of Immune Responses During PneumocystisClinical Center2001–2006
The Role Of Interleukin-2 In The Management Of HIVClinical Center2005
Studies-Lymphocyte Kinetics-Healthy-Hiv-Infected PatientClinical Center2005
Immune Responses During Pneumocystis Carinii PneumoniaClinical Center2005
The Characterization Of P. Carinii Surface AntigensClinical Center1992–2004
Studies On The Role Of Interleukin-2 In The ManagementClinical Center2003
Interleukin-2 In The Management Of HIV InfectionClinical Center2001
Characterization Of Cytokine Responses During Pneumocystis Carinii PneumoniaClinical Center1995–2000
Studies On The Role Of IL-2 In The Management Of HIV InfectionClinical Center1994–1997
Phase I/II Study Of AZT And IL-2 In HIV InfectionClinical Center1990–1992
Isolation And Characterization Of P. Carinii Surface AntigensClinical Center1990–1991
Zidovudine PLUS IL-2 In Treatment Of Hiv-Infected PatientsCenters For Disease Control And Prevention1988
Characteristics Of Pneumocystis Carini AntigensCenters For Disease Control And Prevention1988
Characterization Of Immune Responses During Pneumocystis PneumoniaCLINICAL CENTERPresent
Molecular Studies Of Human and Rodent PneumocystisCLINICAL CENTERPresent
Characterization Of Immune Responses During Pneumocystis PneumoniaCLINICAL CENTERPresent
Evaluation of HIV-related ComplicationsCLINICAL CENTERPresent
Evaluation of HIV-related ComplicationsCLINICAL CENTERPresent
Molecular Studies Of Human and Rodent PneumocystisCLINICAL CENTERPresent
Molecular Studies Of Human and Rodent PneumocystisCLINICAL CENTERPresent
Molecular Studies Of Human and Rodent PneumocystisCLINICAL CENTERPresent
Molecular Studies Of Human and Rodent PneumocystisCLINICAL CENTERPresent

Joseph A Kovacs MD

Dr. Kovacs is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Grant Support

Viewing the full profile is available to verified healthcare professionals only.